AI Summary
illumiSonics and Sunnybrook have launched a clinical trial to validate Multi-Laser Imaging technology as a real-time alternative to traditional frozen-section analysis during Mohs micrographic surgery for skin cancer. This prospective study represents the first in-vivo comparison of the label-free virtual histology technique against the current gold standard in an actual surgical environment.
From the source
First prospective study to validate Multi-Laser Imaging (MLI™) virtual histology against the frozen-section gold standard in a live surgical setting WATERLOO, Ontario & TORONTO — illumiSonics Inc., a medical technology company commercializing label-free tissu…
The full text couldn't be loaded here (the source may require a subscription).
View original at Financial Post